BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28159702)

  • 1. A case of Feingold type 2 syndrome associated with keratoconus refines keratoconus type 7 locus on chromosome 13q.
    Sirchia F; Di Gregorio E; Restagno G; Grosso E; Pappi P; Talarico F; Savin E; Cavalieri S; Giorgio E; Mancini C; Pasini B; Mehta JS; Brusco A
    Eur J Med Genet; 2017 Apr; 60(4):224-227. PubMed ID: 28159702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A de novo 13q31.3 microduplication encompassing the miR-17 ~ 92 cluster results in features mirroring those associated with Feingold syndrome 2.
    Siavrienė E; Preikšaitienė E; Maldžienė Ž; Mikštienė V; Rančelis T; Ambrozaitytė L; Gueneau L; Reymond A; Kučinskas V
    Gene; 2020 Aug; 753():144816. PubMed ID: 32473250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feingold syndrome type 2 in a patient from China.
    Lei J; Han L; Huang Y; Long M; Zhao G; Yan S; Zhang J
    Am J Med Genet A; 2021 Jul; 185(7):2262-2266. PubMed ID: 33818875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo 13q31.1-q32.1 interstitial deletion encompassing the miR-17-92 cluster in a patient with Feingold syndrome-2.
    Tassano E; Di Rocco M; Signa S; Gimelli G
    Am J Med Genet A; 2013 Apr; 161A(4):894-6. PubMed ID: 23495052
    [No Abstract]   [Full Text] [Related]  

  • 5. A fourth case of Feingold syndrome type 2: psychiatric presentation and management.
    Ganjavi H; Siu VM; Speevak M; MacDonald PA
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25391829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2.
    Muriello M; Kim AY; Sondergaard Schatz K; Beck N; Gunay-Aygun M; Hoover-Fong JE
    Am J Med Genet A; 2019 Mar; 179(3):410-416. PubMed ID: 30672094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characterizations of 11 new patients with type 1 Feingold syndrome: Proposal for selecting diagnostic criteria and further genetic testing in patients with severe phenotype.
    Tedesco MG; Lonardo F; Ceccarini C; Cesarano C; Digilio MC; Magliozzi M; Rogaia D; Mencarelli A; Leoni C; Piscopo C; Imperatore V; Falco MT; Fontana P; Nardone AM; Novelli A; Troiani S; Seri M; Prontera P
    Am J Med Genet A; 2021 Apr; 185(4):1204-1210. PubMed ID: 33442900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo 4.4-Mb microdeletion in 2p24.3 → p24.2 in a girl with bilateral hearing impairment, microcephaly, digit abnormalities and Feingold syndrome.
    Chen CP; Lin SP; Chern SR; Wu PS; Chang SD; Ng SH; Liu YP; Su JW; Wang W
    Eur J Med Genet; 2012 Nov; 55(11):666-9. PubMed ID: 22842076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN.
    Burnside RD; Molinari S; Botti C; Brooks SS; Chung WK; Mehta L; Schwartz S; Papenhausen P
    Am J Med Genet A; 2018 Sep; 176(9):1956-1963. PubMed ID: 30088856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GENETIC COUNSELLING IN FEINGOLD SYNDROME AND A NOVEL MUTATION.
    Atik T; Güvenç MS; Onay H; Özkinay F; Çoğulu Ö
    Genet Couns; 2016; 27(3):381-384. PubMed ID: 30204967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.
    Fiori E; Babicola L; Andolina D; Coassin A; Pascucci T; Patella L; Han YC; Ventura A; Ventura R
    Behav Genet; 2015 Sep; 45(5):547-59. PubMed ID: 26026879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metacarpophalangeal pattern profile analysis for a 3-month-old infant with Feingold syndrome 2.
    Isobe A; Maeda N; Fujita H; Banno S; Kageyama T; Hatabu N; Sato R; Suzuki E; Miharu M; Komiyama O; Nakashima M; Matsunaga T; Nishimura G; Yamazawa K
    Am J Med Genet A; 2021 Mar; 185(3):952-954. PubMed ID: 33369046
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models.
    Mirzamohammadi F; Kozlova A; Papaioannou G; Paltrinieri E; Ayturk UM; Kobayashi T
    Nat Commun; 2018 Apr; 9(1):1352. PubMed ID: 29636449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the phenotype of feingold syndrome-2.
    Grote LE; Repnikova EA; Amudhavalli SM
    Am J Med Genet A; 2015 Dec; 167A(12):3219-25. PubMed ID: 26360630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an unusual presentation of Feingold syndrome 1.
    Peleg A; Kurolap A; Sagi-Dain L; Larom-Khan G; Adir V; Mory A; Paperna T; Shuldiner AR; Gonzaga-Jauregui C; Adir N; Baris Feldman H; Wollstein R
    Clin Dysmorphol; 2021 Apr; 30(2):71-75. PubMed ID: 32925198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined deletion 18q22.2 and duplication/triplication 18q22.1 causes microcephaly, mental retardation and leukencephalopathy.
    Nguyen-Minh S; Drossel K; Horn D; Rost I; Spors B; Kaindl AM
    Gene; 2013 Jul; 523(1):92-8. PubMed ID: 23566840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Patient Diagnosed as Feingold Syndrome Type 2 with Alport Syndrome and Review of the Current Literature.
    Demir Ş; Söylemez MA; Arman A; Ata P
    Mol Syndromol; 2022 Dec; 13(5):447-453. PubMed ID: 36588757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic findings in patients with clinical suspicion of 22q11.2 deletion syndrome.
    Koczkowska M; Wierzba J; Śmigiel R; Sąsiadek M; Cabała M; Ślężak R; Iliszko M; Kardaś I; Limon J; Lipska-Ziętkiewicz BS
    J Appl Genet; 2017 Feb; 58(1):93-98. PubMed ID: 27629806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms.
    Fannemel M; Barøy T; Holmgren A; Rødningen OK; Haugsand TM; Hansen B; Frengen E; Misceo D
    Eur J Med Genet; 2014 Sep; 57(9):513-9. PubMed ID: 24911659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features associated with a 15.41 Mb deletion of chromosome 13q encompassing the MIR17HG locus.
    S Sharaidin H; Knipe S; Bain N; Goel H
    Clin Dysmorphol; 2013 Apr; 22(2):68-70. PubMed ID: 23448905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.